Introduction
Secondary postpartum haemorrhage is defined as any abnormal or excessive bleeding from the birth canal occurring between 24 hours 1 and 6 weeks postpartum 2 and, as this definition includes no reference to the volume of blood loss or the condition of the woman, the spectrum of the condition can vary from inconvenient to fatal. However, in developed countries around 1% of postnatal women undergo surgical uterine evacuation for secondary postpartum haemorrhage and a further 1% are admitted to hospital but 3 Leaving aside any physical morbidity, it is generally acknowledged that the postnatal period is a time of significant psychological up-heaval for women and their families even without the added disruption of needing medical treatment and possibly admission to, or extra time in hospital. Secondary postpartum haemorrhage is, however, a topic that has received little attention because it is perceived as being associated with maternal morbidity rather than mortality. 4 Unlike primary postpartum haemorrhage, there is no clear definition for quantity of blood loss and this can vary from 'increased lochia' to massive haemorrhage. The diagnosis is therefore subjective, which may account for the variation in reported incidence. The reported overall incidence of secondary postpartum haemorrhage in the developed world varies from 0.47% to1.44%. 5 The etiology of secondary postpartum haemorrhage is diverse and management is dependent on identifying the cause and tailoring treatment appropriately. The diagnosis of secondary PPH is clinical. Usually there is abrupt onset of heavy bleeding 7-14 days after delivary. Around 10% of cases present with massive obstetrics haemorrhage. It is a diagnosis of exclusion. Ninety-five percent of women present within the first month after delivery, 19% within 7 days, 41% in 8-14 days, 23% in 15-21 days and 12% in 22-28 days. 6 The amount of blood loss at presentation varies but most are hemodynamically stable. A thorough history will provide information relating to cause and should include details regarding parity, labor, mode of delivery, third-stage or puerperal complications and any relevant medical and family history. Clinical signs and symptoms at the time of presentation may include offensive lochia, abdominal cramping, uterine tenderness, pyrexia, enlarged uterus and an open cervical os. Secondary postpartum haemorrhage, which appears frequently to be linked with genital tract infection, still results in maternal death in developed countries albeit very occasionally.
As mentioned previously, the wicked situation occurs when PPH is presented in its secondary form, even if it affects only 1-2% 7 of postnatal women. The published work on the management of secondary PPH is limited compared with primary postpartum hemorrhage . However, with falling maternal mortality rates, there is increasing interest and attention to maternal morbidity and the important topic of management of secondary postpartum haemorrhage. The majority of cases of secondary postpartum haemorrhage are associated with minor morbidities but may still require readmission to hospital, use of antibiotics and surgical intervention. In more extreme cases, major morbidity requiring hysterectomy, arterial ligation or radiological intervention is possible 13 and maternal death may still result from massive secondary postpartum haemorrhage despite the use of all available interventions. 
Inclusion criteria
Women from 24 hours to 6 weeks following a pregnancy of at least 28 weeks gestation with a diagnosis of secondary PPH.
Exclusion criteria
1) Women with bleeding per vagina less than 24 hour 2) Women with bleeding per vagina more than 6 weeks 3) Women less than 28 weeks of gestation
Results
In the study conducted at R.I.M.S Imphal from November 2014 to April 2016 there were 65 women who had secondary PPH, out of whom there were 25(38.5%) para-1, 20(30.8%)para-2, 14(21.5%) para-3, 4(6.1%) para-4 and 2(3.1%) more than para-5.The majority of women were in the age group of 20-30 year(63.1%).The mean age was 27.±6.04. Parity in the present study did not influence the incidence of secondary PPH, and the distribution of its causes was the same in both primiparous and multiparous women. All patients were married and all were non smokers. In 17(26.2%) secondary PPH presented less than 7 days of delivery, 24(36.9%) within 8-14 days, 14(21.5%) within 15-21 days,4(6.2%) within 22-28 days and 6(9.2%) beyond 29 days with P=15.91±9.30.Women with secondary PPH 52(80%) was institutional and 13(20%) was home deliver, labour was induced in 5(7.7%) for maternal or foetal indication and was spontaneous in 60(92.3%).The duration of labour was less than 5 hours in 6(9.2%), 6-10 hours in 50(76.9%), 11 to 15 hours in 5(7.7%) and more than 15 hours 0.0 with Mean±SD:7.36±2.20. In the study 46(70.8%) delivered by NVD, 7(10.8%) by Emergency LSCS, 6(9.2%)preterm Vaginal delivery, 3(4.6%) vaginal birth after caesarean section, 2(3.1%) ventouse vaginal delivery and 1(1.5%) by breech vaginal delivery. Active management of third stage of labour was done in all the cases by control cord traction but in 2(3.1%).patient placenta was manually removed as it was adherent to the uterus. Women admitted with secondary PPH,13(20%) delivered at home and 52(80%) had institutional delivery out of which 17(26.2%) had third stage complication with more than two third having primary PPH 10(15.4%) and traumatic PPH 3(4.6%).The cause of secondary postpartum haemorrhage was retained bits of membrane 24(36.9%%), retained placental tissue 14(21.5%%), purpural sepsis 8(12.3%) and subinvolution of the uterus 19(29.2%) Out of 65 women with secondary PPH,32 (49.2%) women received medical treatment in the form of uterotonic drugs and administration of antibiotic. Antibiotic are commonly given to treat superimposed infection, thought to precipitate the haemorrhage. Uterotonic agents consist of oxytocin (synticinon), prostaglandin F2 alfa (carboprost) and methyl ergometrine. Misoprostol was also given as an alternative. Surgical treatment was given to 33(49.2%) women, check evacuation was done on 26(40%) women, Dilatation and evacuation(D&C) in 4 (6.2%), placental tissue were removed digitally in 2(3.1%) where the cervical os was open and haemostaic suture was taken in 1(1.5%) women with bleeding from the right cervical angle. In women presenting with secondary PPH 40(61.5%) was transfused blood,19(29.2%) women received 1 unit of packed red blood cell (PRBC),14(21.5%) received 2 unit of PRBC, 1(1.5%) received 3 unit PRBC and 5(7.7%) received 4 unit PRBC. only 1(1.5%) women with chronic kidney disease (CKD) was transfused more than 9 units PRBC as she was on dialysis. In the study 24(36.9%) had risk factor like, anaemia 7(10.8%), gestational hypertension 6(9.2%), multiple pregnancy 5(7.7%), premature rupture of membrane (PROM) 2(3.1), twice post caesarean section 2(3.1%), chronic kidney disease 1(1.5%) and HIV reactive 1(1.5%). Secondary postpartum haemorrhage remains an important cause of maternal morbidity. Retained gestational products were more likely to be present when the placenta or membranes were noted to be incomplete at delivery or when there was a history of primary postpartum haemorrhage. As there seems to be no definite risk factor to identify retained products and the high rate of false positive diagnosis with sonography is high, management should probably be guided by the clinical presentation. Unnecessary operative procedure on the puerperal uterus should be avoided and caution should be taken in managing cases following caesarean section.
Conclusion
Unlike primary postpartum haemorrhage, there is no clear definition for quantity of blood loss for secondary postpartum haemorrhage and this can vary from 'increased lochia' to massive haemorrhage. This is not perhaps suprising, since the abnormality is one which usually causes distress and discomfort rather than danger and maternal morbidity rather than mortality. A prospective study was conducted on 65 women presenting with bleeding per vaginum 24 hours to 6 week after delivery with the aim to determine the various factors associated with secondary postpartum haemorrhage and to evaluate the medical or surgical intervention needed. A detailed clinical history including parity, obstetrical history, duration of labour, mode and place of delivery and third stage complication was taken. General and systemic examination done and all the routine investigations including ultrasonography were carried out where necessary. Retained bits of membrane (36.9%) and subinvolution of the uterus (29.2%) was the two most common cause of secondary PPH followed by retained placental tissue (21.5%) and puerperal sepsis (12.3%). Medical treatment was given to 49.2% of women but 50.8% of the women with secondary PPH had surgical intervention Finding from this study suggest that it would be useful to conduct a population-based prospective cohort study to verify the incidence of secondary PPH and to assess its predictive factors. Thus women having risks of secondary PPH would receive individual risk based counseling before their hospital discharge.
